Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Pioglitazone + Vitamin E versus Metformin + Ursodeoxycholic acid in fatty liver disease
IRCT20180404039187N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Dec 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pioglitazone, vitamin e, metformin and ursodeoxycholic acid in steatosis (2 arms), sponsored by Tabriz University of Medical Sciences. Started Dec 2018; status: completed.
02
Drugs
pioglitazonevitamin emetforminursodeoxycholic acid
03
Conditions
steatosis
Beyond the preview
Go deeper on IRCT20180404039187N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180404039187N1.